BAL PHARMA
Back to Balance Sheet
|
BAL PHARMA Last 5 Year Total Non-Current Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Non-Current Liabilities | ₹38 Cr | ₹45 Cr | ₹38 Cr | ₹36 Cr | ₹34 Cr |
What is the latest Total Non-Current Liabilities ratio of BAL PHARMA ?
| Year | Total Non-Current Liabilities |
|---|---|
| Mar2025 | ₹38 Cr |
| Mar2024 | ₹45 Cr |
| Mar2023 | ₹38 Cr |
| Mar2022 | ₹36 Cr |
| Mar2021 | ₹34 Cr |
How is Total Non-Current Liabilities of BAL PHARMA Trending?
| Years | Total Non-Current Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹38 Cr | -14.36 | |
| Mar2024 | ₹45 Cr | 18.02 | |
| Mar2023 | ₹38 Cr | 4.32 | |
| Mar2022 | ₹36 Cr | 6.44 | |
| Mar2021 | ₹34 Cr | - | |
Compare Total Non-Current Liabilities of peers of BAL PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| BAL PHARMA | ₹141.0 Cr | 1.8% | 13.5% | -10.8% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹467,870.0 Cr | -1.4% | 2.4% | 17.1% | Stock Analytics | |
| DIVIS LABORATORIES | ₹220,946.0 Cr | 12.2% | 23.1% | 21.7% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹190,907.0 Cr | 2.4% | 5.3% | 41.7% | Stock Analytics | |
| CIPLA | ₹118,674.0 Cr | 1.7% | 0.7% | -3.8% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹97,648.7 Cr | 3% | -14.9% | -10.2% | Stock Analytics | |
BAL PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| BAL PHARMA | 1.8% |
13.5% |
-10.8% |
| SENSEX | 2.4% |
1.5% |
-4.3% |
You may also like the below Video Courses